Gönül ŞENGÖZ, Filiz YILDIRIM, Kart Kadriye YAŞAR, Mehmet BAKAR, Özcan NAZLICAN, KADİR İDİN, Ejder ÖZENÇ

Features of tetanus in eight adult patients in İstanbul metropolis

Tetanoz aşı ile korunabilir bir hastalık olmasına rağmen aşılamadaki eksikliklere bağlı olarak hala görülebilmektedir. Biz 1998-2002 yılları arasında tetanozlu sekiz erişkin hastayı izledik (ort. yaş 44, olguların %75'i erkek). Tetanoz, hastalarda cerrahi yaralanma, yanık, hayvan ısırığı ya da küçük yaralanmalarla oluşmuştu. Hastaların beşi yaralandığında tıbbi bakım görmüştü. Dört hastada yara bakımı yapılmış, ama sadece bir hastaya tetanoz aşısı uygulanmıştı ve hastaların hiçbiri tetanoz immünglobulini almamıştı (TIG). Tetanoz hastaların yarısında fatal seyretti ve ölümler 2 ila 30. günler arasında gerçekleşti. Küçük yaralanmalar da bu fatalitesi yüksek hastalık için risk oluşturmaktadır ve hastaların primer aşılanma anamnezleri tedavi için çok önemlidir. Başta acil bölümlerde çalışanlar olmak üzere sağlık çalışanlarındaki, hastalığın bilinirliği ve farkındalığı periyodik olarak yenilenmelidir. Yara bakımı, TIG ve tetanoz aşısı uygulamaları primer aşılama kadar önemlidir.

Anahtar Kelimeler:

Erişkin, Orta yaşlı, Tetanos, Aşılama, Genç erişkin

İstanbul metropolünde izlenen sekiz erişkin tetanuslu hastanın özellikleri

Although tetanus is a vaccine-preventable disease, it still occurs due to deficiency in vaccination. We followed eight patients (median age 44 years; %75 men) with tetanus referred to our center between 1998-2002. They had contracted tetanus by surgical wound, burn, animal bite or minor wounds. Five of them had sought medical care when injured. Their wounds were treated (four patients), but tetanus vaccination was applied to only one patient, none were given tetanus immune globulin (TIG). Tetanus was fatal in half of the patients and death occurred within 2-30 days. Even minor injuries carry a risk for this highly fatal illness, and the patients' primary vaccination history is very important for treatment. Knowledge and awareness of healthcare workers, especially emergency department workers should be refreshed periodically. Wound treatment, TIG and tetanus toxoid applications are as important as primary immunization.

Keywords:

Adult, Middle Aged, Tetanus, Vaccination, Young Adult,

PDF

___

1) Bleck TP. Clostridium tetani (tetanus). In: Mandell GL, Bennett JE, Dolin R, editors. Principles and practice of infectious diseases. 6th ed. New York: Elsevier Churchill Livingstone; 2005. p. 2817-22.
2) General Directorate of Basic Health Services. Annual statistics 2001 (table 44). Available from: http://www.saglik.gov.tr/TR/Genel/BelgeGoster.aspx?F6E10F8892433CFF71BE64510F6C8BC9BCE6CB6771470A25.
3) Saltoğlu N, Tasova Y, Arslan A, Dündar IH. Evaluation of immunization history, clinical features, therapy and prognosis of tetanus cases. Klimik Derg 1997;10:69-72.
4) Durán-Nah J, Ceh-Gómez E, Díaz-Cervera I, Mis-Fernández R. Epidemiologic features of tetanus in adults form Yucatan, Mexico. [Article in Spanish] Rev Invest Clin 2001;53:536-42. [Abstract]
5) Miranda-Filho DB, Ximenes RA, Bernardino SN, Escarião AG. Identification of risk factors for death from tetanus in Pernambuco, Brazil: a case-control study. Rev Inst Med Trop Sao Paulo 2000;42:333-9.
6) Alexander WJ, Cannon NJ, Crow CB, Cobbs CG. Recent experience with tetanus in Alabama. South Med J 1978;71:1092-4.
7) Porter JD, Perkin MA, Corbel MJ, Farrington CP, Watkins JT, Begg NT. Lack of early antitoxin response to tetanus booster. Vaccine 1992;10:334-6.
8) Massari M, D'Adamo F, Santucci G. Treatment with human tetanus immunoglobulins in the Emergency Department. Effects of informed consent. [Article in Italian] Minerva Med 1997;88:435-9. [Abstract]
9) Hüllstrung HD, Mäusezahl D, Feuz M, Herzog C, Conzelmann M, Zimmerli W. Tetanus immunisation in geriatric patients with accidental wounds: how much is needed? Swiss Med Wkly 2003;133:227-32.
10) Atabay N, Gokoglu M. Serum antitoxin levels by time after tetanus immunization. Türk Mikrobiyol Cem Derg 1992;22:101-4.
11) Olsen KM, Hiller FC. Management of tetanus. Clin Pharm 1987;6:570-4.
12) Lubbad EH, Khazindar AM, Ayyub M. Tetanus experience in a public hospital in Western Saudi Arabia. Saudi Med J 2003;24:1325-8.
13) Prospero E, Appignanesi R, D'Errico MM, Carle F. Epidemiology of tetanus in the Marches Region of Italy, 1992-95. Bull World Health Organ 1998;76:47-54.
14) Pascual FB, McGinley EL, Zanardi LR, Cortese MM, Murphy TV. Tetanus surveillance--United States, 1998--2000. MMWR Surveill Summ 2003;52:1-8.
15) Schröder JP, Kuhlmann WD. Tetanus immunity in men and women in the Federal Republic of Germany. [Article in German] Immun Infekt 1991;19:14-7. [Abstract]
16) Yuce A. Cases of tetanus and relevant problems. Turkish Journal of Infection 1988;2:23-6.
17) Ergonul O, Erbay A, Eren S, Dokuzoguz B. Analysis of the case fatality rate of tetanus among adults in a tertiary hospital in Turkey. Eur J Clin Microbiol Infect Dis 2003;22:188-90.
18) Ahmed SI, Baig L, Thaver IH, Siddiqui MI, Jafery SI, Javed A. Knowledge, attitudes and practices of general practitioners in Karachi District Central about tetanus immunization in adults. J Pak Med Assoc 2001;51:367-9.